nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—CYP3A4—Clindamycin—malaria	0.167	0.214	CbGbCtD
Linagliptin—CYP3A4—Sulfadiazine—malaria	0.0961	0.123	CbGbCtD
Linagliptin—ABCB1—Quinine—malaria	0.0827	0.106	CbGbCtD
Linagliptin—CYP3A4—Artemether—malaria	0.0817	0.105	CbGbCtD
Linagliptin—CYP3A4—Proguanil—malaria	0.0769	0.0984	CbGbCtD
Linagliptin—CYP3A4—Doxycycline—malaria	0.0729	0.0933	CbGbCtD
Linagliptin—ABCB1—Quinidine—malaria	0.0727	0.093	CbGbCtD
Linagliptin—CYP3A4—Quinine—malaria	0.0495	0.0634	CbGbCtD
Linagliptin—CYP3A4—Quinidine—malaria	0.0435	0.0557	CbGbCtD
Linagliptin—CYP3A4—Dapsone—malaria	0.0375	0.0481	CbGbCtD
Linagliptin—DPP4—blood plasma—malaria	0.0102	0.166	CbGeAlD
Linagliptin—DPP4—saliva-secreting gland—malaria	0.00592	0.096	CbGeAlD
Linagliptin—DPP4—hematopoietic system—malaria	0.00565	0.0916	CbGeAlD
Linagliptin—DPP4—kidney—malaria	0.00463	0.0751	CbGeAlD
Linagliptin—Skin exfoliation—Sulfadiazine—malaria	0.00438	0.0278	CcSEcCtD
Linagliptin—DPP4—digestive system—malaria	0.00393	0.0637	CbGeAlD
Linagliptin—DPP4—blood—malaria	0.00374	0.0607	CbGeAlD
Linagliptin—DPP4—bone marrow—malaria	0.00362	0.0587	CbGeAlD
Linagliptin—Hypoglycaemia—Sulfadiazine—malaria	0.00341	0.0217	CcSEcCtD
Linagliptin—Skin exfoliation—Dapsone—malaria	0.00337	0.0214	CcSEcCtD
Linagliptin—CYP3A4—blood plasma—malaria	0.00333	0.054	CbGeAlD
Linagliptin—Skin exfoliation—Clindamycin—malaria	0.00326	0.0207	CcSEcCtD
Linagliptin—Anaphylactic shock—Pyrimethamine—malaria	0.00316	0.0201	CcSEcCtD
Linagliptin—Immune system disorder—Proguanil—malaria	0.00313	0.0199	CcSEcCtD
Linagliptin—Mediastinal disorder—Proguanil—malaria	0.00313	0.0199	CcSEcCtD
Linagliptin—Malnutrition—Proguanil—malaria	0.00302	0.0192	CcSEcCtD
Linagliptin—DPP4—liver—malaria	0.00293	0.0475	CbGeAlD
Linagliptin—Pancreatitis—Sulfadiazine—malaria	0.00282	0.0179	CcSEcCtD
Linagliptin—Cough—Proguanil—malaria	0.00264	0.0167	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Proguanil—malaria	0.00255	0.0162	CcSEcCtD
Linagliptin—Hypoglycaemia—Quinidine—malaria	0.00249	0.0158	CcSEcCtD
Linagliptin—Hypoglycaemia—Quinine—malaria	0.00249	0.0158	CcSEcCtD
Linagliptin—Skin disorder—Proguanil—malaria	0.00239	0.0152	CcSEcCtD
Linagliptin—ABCB1—blood plasma—malaria	0.00236	0.0382	CbGeAlD
Linagliptin—Hypersensitivity—Pyrimethamine—malaria	0.00233	0.0148	CcSEcCtD
Linagliptin—DPP4—brain—malaria	0.00232	0.0377	CbGeAlD
Linagliptin—Nasopharyngitis—Dapsone—malaria	0.00229	0.0146	CcSEcCtD
Linagliptin—Hypoglycaemia—Quinidine barbiturate—malaria	0.00225	0.0143	CcSEcCtD
Linagliptin—Pancreatitis—Dapsone—malaria	0.00217	0.0138	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Proguanil—malaria	0.00213	0.0135	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Clindamycin—malaria	0.00199	0.0127	CcSEcCtD
Linagliptin—Urinary tract infection—Clindamycin—malaria	0.00186	0.0118	CcSEcCtD
Linagliptin—CYP3A4—hematopoietic system—malaria	0.00184	0.0299	CbGeAlD
Linagliptin—Arthralgia—Sulfadiazine—malaria	0.00171	0.0108	CcSEcCtD
Linagliptin—Infestation—Pentoxifylline—malaria	0.00169	0.0107	CcSEcCtD
Linagliptin—Infestation NOS—Pentoxifylline—malaria	0.00169	0.0107	CcSEcCtD
Linagliptin—Diarrhoea—Proguanil—malaria	0.00169	0.0107	CcSEcCtD
Linagliptin—Anaphylactic shock—Sulfadiazine—malaria	0.00164	0.0104	CcSEcCtD
Linagliptin—Rash—Proguanil—malaria	0.00155	0.00987	CcSEcCtD
Linagliptin—Dermatitis—Proguanil—malaria	0.00155	0.00986	CcSEcCtD
Linagliptin—Headache—Proguanil—malaria	0.00154	0.00981	CcSEcCtD
Linagliptin—Immune system disorder—Quinidine—malaria	0.00152	0.00965	CcSEcCtD
Linagliptin—Immune system disorder—Quinine—malaria	0.00152	0.00965	CcSEcCtD
Linagliptin—Mediastinal disorder—Quinine—malaria	0.00152	0.00963	CcSEcCtD
Linagliptin—Mediastinal disorder—Quinidine—malaria	0.00152	0.00963	CcSEcCtD
Linagliptin—CYP3A4—kidney—malaria	0.00151	0.0245	CbGeAlD
Linagliptin—Musculoskeletal discomfort—Sulfadiazine—malaria	0.00149	0.00947	CcSEcCtD
Linagliptin—Malnutrition—Quinine—malaria	0.00146	0.0093	CcSEcCtD
Linagliptin—Malnutrition—Quinidine—malaria	0.00146	0.0093	CcSEcCtD
Linagliptin—Back pain—Clindamycin—malaria	0.00144	0.00917	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Sulfadiazine—malaria	0.00141	0.00897	CcSEcCtD
Linagliptin—Immune system disorder—Quinidine barbiturate—malaria	0.00137	0.00871	CcSEcCtD
Linagliptin—Immune system disorder—Pentoxifylline—malaria	0.00137	0.0087	CcSEcCtD
Linagliptin—Mediastinal disorder—Quinidine barbiturate—malaria	0.00137	0.00869	CcSEcCtD
Linagliptin—Cough—Dapsone—malaria	0.00135	0.00856	CcSEcCtD
Linagliptin—Angioedema—Quinidine—malaria	0.00134	0.0085	CcSEcCtD
Linagliptin—Angioedema—Quinine—malaria	0.00134	0.0085	CcSEcCtD
Linagliptin—Malnutrition—Quinidine barbiturate—malaria	0.00132	0.0084	CcSEcCtD
Linagliptin—ABCB1—hematopoietic system—malaria	0.0013	0.0212	CbGeAlD
Linagliptin—Urticaria—Sulfadiazine—malaria	0.0013	0.00826	CcSEcCtD
Linagliptin—CYP3A4—digestive system—malaria	0.00128	0.0208	CbGeAlD
Linagliptin—Back pain—Pentoxifylline—malaria	0.00128	0.00811	CcSEcCtD
Linagliptin—Myalgia—Quinidine—malaria	0.00125	0.00792	CcSEcCtD
Linagliptin—Myalgia—Quinine—malaria	0.00125	0.00792	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.00124	0.00787	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.00124	0.00787	CcSEcCtD
Linagliptin—CYP3A4—blood—malaria	0.00122	0.0198	CbGeAlD
Linagliptin—Anaphylactic shock—Clindamycin—malaria	0.00122	0.00774	CcSEcCtD
Linagliptin—Angioedema—Quinidine barbiturate—malaria	0.00121	0.00767	CcSEcCtD
Linagliptin—Angioedema—Pentoxifylline—malaria	0.00121	0.00766	CcSEcCtD
Linagliptin—Hypersensitivity—Sulfadiazine—malaria	0.00121	0.00766	CcSEcCtD
Linagliptin—Skin disorder—Quinidine—malaria	0.00116	0.00738	CcSEcCtD
Linagliptin—Skin disorder—Quinine—malaria	0.00116	0.00738	CcSEcCtD
Linagliptin—Arthralgia—Quinidine barbiturate—malaria	0.00113	0.00715	CcSEcCtD
Linagliptin—Myalgia—Quinidine barbiturate—malaria	0.00113	0.00715	CcSEcCtD
Linagliptin—Myalgia—Pentoxifylline—malaria	0.00112	0.00714	CcSEcCtD
Linagliptin—Diarrhoea—Sulfadiazine—malaria	0.00112	0.00711	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.00112	0.0071	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.00112	0.00709	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Quinidine—malaria	0.00109	0.00692	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Quinine—malaria	0.00109	0.00692	CcSEcCtD
Linagliptin—Anaphylactic shock—Pentoxifylline—malaria	0.00108	0.00684	CcSEcCtD
Linagliptin—Infection—Pentoxifylline—malaria	0.00107	0.0068	CcSEcCtD
Linagliptin—ABCB1—kidney—malaria	0.00107	0.0173	CbGeAlD
Linagliptin—Gastrointestinal disorder—Clindamycin—malaria	0.00105	0.00668	CcSEcCtD
Linagliptin—Skin disorder—Quinidine barbiturate—malaria	0.00105	0.00666	CcSEcCtD
Linagliptin—Skin disorder—Pentoxifylline—malaria	0.00105	0.00664	CcSEcCtD
Linagliptin—Constipation—Clindamycin—malaria	0.00104	0.00662	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Quinine—malaria	0.00103	0.00656	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Quinidine—malaria	0.00103	0.00656	CcSEcCtD
Linagliptin—Rash—Sulfadiazine—malaria	0.00103	0.00655	CcSEcCtD
Linagliptin—Dermatitis—Sulfadiazine—malaria	0.00103	0.00655	CcSEcCtD
Linagliptin—Headache—Sulfadiazine—malaria	0.00103	0.00651	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000983	0.00624	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000981	0.00623	CcSEcCtD
Linagliptin—Urticaria—Clindamycin—malaria	0.000968	0.00615	CcSEcCtD
Linagliptin—CYP3A4—liver—malaria	0.000955	0.0155	CbGeAlD
Linagliptin—Urticaria—Quinidine—malaria	0.00095	0.00603	CcSEcCtD
Linagliptin—Urticaria—Quinine—malaria	0.00095	0.00603	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000932	0.00592	CcSEcCtD
Linagliptin—Constipation—Quinidine barbiturate—malaria	0.000923	0.00586	CcSEcCtD
Linagliptin—Constipation—Pentoxifylline—malaria	0.000921	0.00585	CcSEcCtD
Linagliptin—ABCB1—digestive system—malaria	0.000907	0.0147	CbGeAlD
Linagliptin—Hypersensitivity—Clindamycin—malaria	0.000898	0.0057	CcSEcCtD
Linagliptin—Hypersensitivity—Quinidine—malaria	0.000881	0.00559	CcSEcCtD
Linagliptin—Hypersensitivity—Quinine—malaria	0.000881	0.00559	CcSEcCtD
Linagliptin—ABCB1—blood—malaria	0.000864	0.014	CbGeAlD
Linagliptin—Urticaria—Quinidine barbiturate—malaria	0.000857	0.00544	CcSEcCtD
Linagliptin—Urticaria—Pentoxifylline—malaria	0.000856	0.00543	CcSEcCtD
Linagliptin—ABCB1—bone marrow—malaria	0.000836	0.0136	CbGeAlD
Linagliptin—Diarrhoea—Clindamycin—malaria	0.000834	0.0053	CcSEcCtD
Linagliptin—Diarrhoea—Quinidine—malaria	0.000818	0.0052	CcSEcCtD
Linagliptin—Diarrhoea—Quinine—malaria	0.000818	0.0052	CcSEcCtD
Linagliptin—Hypersensitivity—Quinidine barbiturate—malaria	0.000795	0.00505	CcSEcCtD
Linagliptin—Hypersensitivity—Pentoxifylline—malaria	0.000794	0.00504	CcSEcCtD
Linagliptin—Headache—Dapsone—malaria	0.000789	0.00501	CcSEcCtD
Linagliptin—Rash—Clindamycin—malaria	0.000768	0.00488	CcSEcCtD
Linagliptin—Dermatitis—Clindamycin—malaria	0.000768	0.00488	CcSEcCtD
Linagliptin—Headache—Clindamycin—malaria	0.000763	0.00485	CcSEcCtD
Linagliptin—Rash—Quinidine—malaria	0.000754	0.00479	CcSEcCtD
Linagliptin—Rash—Quinine—malaria	0.000754	0.00479	CcSEcCtD
Linagliptin—Dermatitis—Quinine—malaria	0.000753	0.00478	CcSEcCtD
Linagliptin—Dermatitis—Quinidine—malaria	0.000753	0.00478	CcSEcCtD
Linagliptin—Headache—Quinine—malaria	0.000749	0.00476	CcSEcCtD
Linagliptin—Headache—Quinidine—malaria	0.000749	0.00476	CcSEcCtD
Linagliptin—Diarrhoea—Quinidine barbiturate—malaria	0.000738	0.00469	CcSEcCtD
Linagliptin—Diarrhoea—Pentoxifylline—malaria	0.000737	0.00468	CcSEcCtD
Linagliptin—Rash—Quinidine barbiturate—malaria	0.00068	0.00432	CcSEcCtD
Linagliptin—Dermatitis—Quinidine barbiturate—malaria	0.00068	0.00432	CcSEcCtD
Linagliptin—Rash—Pentoxifylline—malaria	0.000679	0.00431	CcSEcCtD
Linagliptin—Dermatitis—Pentoxifylline—malaria	0.000678	0.00431	CcSEcCtD
Linagliptin—Headache—Quinidine barbiturate—malaria	0.000676	0.00429	CcSEcCtD
Linagliptin—ABCB1—liver—malaria	0.000676	0.011	CbGeAlD
Linagliptin—Headache—Pentoxifylline—malaria	0.000675	0.00429	CcSEcCtD
Linagliptin—ABCB1—brain—malaria	0.000536	0.00869	CbGeAlD
